central and peripheral glp-1 systems independently suppress eating The GLP-1: implications for food drug reward Novel neural pathways targeted by

[13] [14] What dose will I get, and how often

For more on weight-loss drugs, see our blog series.

While GLP-1RA continue to be successful 17 , combinatorial approaches are being developed due to the hypothesis that additional pathway engagement will generate greater weight loss, durability of weight loss and improved tolerability 7

Ed Warner, the UK Athletics (UKA) chairman, told MPs that not recording injections was "inexcusable" although Dr Chakraverty said record keeping had since improved

As a GLP-1 receptor agonist, semaglutide presents an exciting opportunity for patients seeking to manage their type 2 diabetes and achieve weight loss goals